Lind Global Fund II LP 13D and 13G filings for Constellation Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-21 4:52 pm Purchase |
2023-02-16 | 13G | Constellation Pharmaceuticals, Inc. CNST |
Lind Global Fund II LP | 1,505,000 9.900% |
1,505,000 (New Position) |
Filing |
| 2023-02-21 4:51 pm Purchase |
2023-02-17 | 13G | Constellation Pharmaceuticals, Inc. CNST |
Lind Global Fund II LP | 1,018,518 6.200% |
1,018,518 (New Position) |
Filing |